echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > ARD: Genome sequencing and functional analysis to identify MAP4K3/GLK germline and somatic mutations associated with systemic lupus erythematosus

    ARD: Genome sequencing and functional analysis to identify MAP4K3/GLK germline and somatic mutations associated with systemic lupus erythematosus

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Overexpression of MAP4K3 (GLK) in


    Overexpression of MAP4K3 (GLK) in





    in conclusion:

    Conclusion: Conclusion:

    Multiple GLK germline and somatic mutations in SLE patients induce GLK overexpression by increasing mRNA or protein stability .


    Multiple GLK germline and somatic mutations in SLE patients induce GLK overexpression by increasing mRNA or protein stability .


    Source:

    Chuang HC, Hung WT, Chen YM, Hsu PM, Yen JH, Lan JL, Tan TH.


    Chuang HC, Hung WT, Chen YM, Hsu PM, Yen JH, Lan JL, Tan TH.
    Genomic sequencing and functional analyses identify MAP4K3/GLK germline and somatic variants associated with systemic lupus erythematosus.
    Ann Rheum Dis.
    2021 Oct 5: annrheumdis- 2021-221010.
    doi: 10.
    1136/annrheumdis-2021-221010.
    Epub ahead of print.
    PMID: 34610951.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.